China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and safety of layered embolization with uniform drug-eluting microspheres for intermediate and advanced primary hepatocellular carcinoma'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600129486
Registration Time: 2026/08/05
Type: Interventional study
Primary Sponsor: The First Affiliated Hospital of Zhengzhou University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=288752
Published by HT Digital Content Services with permission from Health Daily Digest....